# EDGAR Filing Document

**Accession Number:** 0002070887
**File Stem:** 0000000000-25-007805
**Filing Date:** 2025-7
**Character Count:** 7066
**Document Hash:** 739986ae14f8575f60e2a1ea01bd007e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-007805.hdr.sgml**: 20260224

**ACCESSION NUMBER**: 0000000000-25-007805

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250724

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Crown Reserve Acquisition Corp. I
- **CENTRAL INDEX KEY:** 0002070887
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-287674

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** CRICKET SQUARE
- **STREET 2:** HUTCHINS DRIVE PO BOX 2681
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
- **ZIP:** 00000
- **BUSINESS PHONE:** 5167139590

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** CRICKET SQUARE
- **STREET 2:** HUTCHINS DRIVE PO BOX 2681
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
- **ZIP:** 00000
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-25-049453

## Text-Extract

```

                                                            July 24, 2025

Prashant Patel
Chairman and Chief Executive Officer
Crown Reserve Acquisition Corp. I
Conyers Trust Company (Cayman) Limited
Cricket Square, Hutchins Drive
PO Box 2681
Grand Cayman KY1-1111
Cayman Islands

        Re: Crown Reserve Acquisition Corp. I
            Amendments No. 1 and 2 to Registration Statement on Form S-1
            Filed July 11, 2025
            Amendment No. 3 to Registration Statement on Form S-1
            Filed July 16, 2025
            File No. 333-287674
Dear Prashant Patel:

     We have reviewed your amended registration statement and have the
following
comments.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our June 25,
2025 letter.

Amendment No. 3 to Form S-1
Summary
Previous SPAC Experience, page 5

1.     We note your revised disclosure in response to prior comment 8, but we
note that your
       statements continue to refer to outdated information. Please further
revise to remove
       outdated listing information with respect to references to exchanges and
ticker
       symbols. In this regard, as one example only, we note that the
information relating to
 July 24, 2025
Page 2

       OceanTech Acquisitions I Corp. does not appear current, and we also note
that the
       ticker symbol and/or exchange you have listed for some companies do not
appear to
       be correct.
Risk Factors
If we seek shareholder approval of our initial business combination . . ., page
48

2.     We acknowledge your revised disclosures in response to prior comment 15.
However,
       your revised disclosure here, and elsewhere in your prospectus, states
that assuming
       that only the holders of one-half of your issued and outstanding
ordinary shares,
       representing a quorum under your amended and restated memorandum and
articles of
       association, vote their ordinary shares at an extraordinary general
meeting, you will
       need approximately 5.6% of the 15,000,000 public shares sold in this
offering to
       approve the initial business combination, in addition to the shares held
by insiders.
       However, you also have a similar statement indicating that you would
need 16.3% of
       such shares. Please revise to clarify or otherwise reconcile your
statements. In
       addition, please revise to clarify whether SAP is required to vote the
SAP shares to
       approve the initial business combination and whether your calculations
include such
       shares.
Dilution, page 89

3.     We note your response to our prior comment 19 and revised disclosure
confirming
       that redemptions in connection with a business combination cannot cause
your net
       tangible assets to fall below $5,000,001, thereby capping the maximum
redemptions
       permitted. Please amend your tabular dilution disclosure to present
dilution at quartile
       intervals based on percentages of your maximum redemption threshold, and
not based
       on absolute percentages of shares issued in connection with your
offering (e.g., 25%
       of maximum redemption, not 25% of public offering). Refer to Item
1602(a)(4) of
       Regulation S-K. In addition, update such amounts throughout your
prospectus
       accordingly.
Management, page 132

4.     We note your response to prior comment 20. Please further revise your
disclosures to
       ensure compliance with Item 401(e) of Regulation S-K. For example,
please clarify
       your disclosures regarding Eric Sherb to disclose the business
experience, principal
       occupations, and employment during each of the past five years,
including dates and
       duration of employment. We also note that Avinash Wadhwani does not
currently
       appear to be a director of Semper Paratus Acquisition Corporation (now
doing
       business as Tevogen Bio since its initial business combination).
Underwriting, page 179

5.     We note your revised disclosure in response to prior comment 29 and
re-issue, as it
       does not appear that you have revised your underwriter's compensation
table to
       include the SAP units. Please revise the table to include such units, or
advise.
       See Item 508(e) of Regulation S-K.
 July 24, 2025
Page 3

Financial Statements
Notes to Financial Statements
Note 4 - Related Party Transactions
Promissory Note - Related Party, page F-13

6.     Please tell us why you have updated the estimated amount of offering
expenses to
       $500,000, and address why such amount differs from the estimated amount
of such
       expenses totaling $580,000 as disclosed elsewhere throughout your
prospectus.
Exhibit 23.1, page II-2

7.     Please amend your prospectus to provide a currently dated consent from
your
       independent registered public accounting firm.
       Please contact Peter McPhun at 202-551-3581 or Mark Rakip at
202-551-3573 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Isabel Rivera at 202-551-3518 or Dorrie Yale at 202-551-8776 with any
other
questions.

                                                         Sincerely,

                                                         Division of
Corporation Finance
                                                         Office of Real Estate
& Construction
cc:   Rajiv Khanna, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._